Bis(phosphane)-Linked (η6-p-Cymene)ruthenium(ii)–Borane Compounds
FULL PAPER
2
{11B@δ = –37.3} δ = 1.30, d, JPH = 17.0]. 13C{1H} NMR RuP(m-C6H5Ј)2CCPPh2], 5.73–5.80 [m, 1 H, o-CH3C6H4Ј {31P@δ
2
3
3
(CDCl3, –50 °C): δ = 133.3 [d, JPC = 10.6, RuP(p-C6H5)2], 132.7
= 5.7} δ = 5.77, d, JHH = 6.3], 5.70 (d, JHH = 6.1, 1 H, m-
2
[s, P(p-C6H5)2BH3], 132.4 [d, JPC = 11.6, P(p-C6H5)2BH3], 131.4
CH3C6H4), 5.30–5.23 [m, 1 H, o-CH3C6H4 {31P@δ = 24.5} δ =
1
3
3
3
[s, RuP(p-C6H5)2], 130 [d, JPC ca. 60, P(i-C6H5)2], 129.6 [d, JPC
=
5.26, d, JHH = 6.5], 5.07 (d, JHH = 6.1, 1 H, m-CH3C6H4Ј), 2.80
11.3, P(m-C6H5)2BH3], 128.7 [d, 3JPC = 11.0, RuP(m-C6H5)2], 126.7 [sept, 3JHH = 6.9, 1 H, CH(CH3)2], 0.8–1.8 [br., 3 H, BH3; {11B@δ
1
1
2
3
[d, JPC = 64.6, P(i-C6H5)2], 110.4 [s, CCH(CH3)2], 104.5 [dd, JPC
= 65.7, 2JPC = 7.5, PCCP], 99.2 (dd, 1JPC = 89.4, 2JPC Ͻ 2, PCCP),
96.9 (s, CH3–C), 90.0 (d, JPC = 3.5, o-CH3C6H4), 87.4 (d, JPC
= –37.7} δ = 1.46, d, JPH = 16.2], 1.1–1.4 [m, JHH = 6.4, 9 H,
CH(CH3)2, CH(CH3Ј)2 and CH3–C6H4]. 13C{1H} NMR (CDCl3,
–50 °C): δ = 128–134 (poorly resolved, PPh), 133 [pend-P(o-C6H5)2
2
2
=
5.6, m-CH3C6H4), 30.5 [s, CH(CH3)2], 21.9 [s, CH(CH3)2], 17.9 (s, and pend-P(o-C6ЈH5)2], 132 [RuP(o-C6H5)3], 131 [CCH(CH3)2], 129
CH3–C6H4). 31P{1H} NMR (CDCl3, –50 °C): δ = 5.8 (br., 1 P, [RuP(m-C6ЈH5)2CCPPh2], 125.6 (m, RuPPh2CCPPh2), 99 (CH3–C),
PBH3), 3.2 (s, 1 P, RuP). 11B{1H} NMR (CDCl3): δ = –37.3 (br).
Preparation of [(η6-p-Cymene)RuCl(PPh3)(η1-PPh2CCPPh2)]PF6
99 (o-CH3C6H4), 97 (o-CH3C6ЈH4), 91 (m-CH3C6ЈH4), 90 (m-
CH3C6H4), 31.6 [s, CH(CH3)2], 21.8 [s, CH(CH3)2 or CH(CЈH3)2],
21.5 [s, CH(CЈH3)2 or CH(CH3)2], 15.1 (s, CH3–C6H4). 31P{1H}
(7):
A
suspension of [(η6-p-cymene)RuCl2(PPh3)] (0.70 g,
2
NMR (CDCl3): δ = 24.5 (d, JPP = 55.1, 1 P, Ru–PPh3), 7.8 (br., 1
1.23 mmol), [NH4]PF6 (0.20 g, 1.23) and dppa (0.49 g, 1.23 mmol)
in MeOH (150 mL) was heated at 35 °C for 3 h. The solvent was
removed in vacuo, and the residue taken up in a minimal amount
of CH2Cl2. A small amount of (unidentified) solid material was
removed by the addition of hexane and filtration. Removal of the
solvent gave an orange oil that solidified under high vacuum. Yield:
3
P, P–BH3), 5.7 (d, JPP = 55.1, 1 P, Ru–PPh2), –144.3 (sept, 1JPF
=
712.7, 1 P, PF6). 11B{1H} NMR (CDCl3): δ = –37.7 (br). IR (nujol,
cm–1): ν = ν(CC) not observed; ν(BH) 2393 (br). ESI-MS (MeOH)
˜
positive ion: m/z = 927 (100) [M – BH3]+, 941 (10) [M]+. ESI-MS
(CH2Cl2) positive ion: m/z = 927 (14) [M – BH3]+, 941 (100) [M]+.
ESI-MS2 (+941): m/z = 927 [M – BH3]+. ESI-MS3 (+941; +927):
m/z = 665 [M – PPh3 – BH3]+. ESI-MS (CH2Cl2) negative ion:
m/z = 145 (100) [PF6]–.
1
3
3
0.74 g (56%). H NMR (CDCl3): δ = 7.97 [dd, JHH = 7.2, JPH
=
12.3, 2 H, RuP(o-C6H5)2CCPPh2], 7.60–7.75 [m, 4 H, pend-P(o-
C6H5)2 and pend-P(o-C6H5Ј)2], 7.30–7.60 (m, 20 H, PPh), 7.10–
4
7.25 [m, 7 H, RuP(m-C6H5)3 and RuP(p-C6H5Ј)2], 6.92 [td, JPH
=
Preparation of [(η6-p-Cymene)RuCl2(η1-PPh2CH2PPh2BH3)] (1B):
2.9, 3JHH = 7.7, 2 H, RuP(m-C6H5Ј)2CCPPh2], 5.66 (d, 3JHH = 6.2,
To
a
solution of [(η6-p-cymene)RuCl2(η1-dppm)] (0.08 g,
1 H, m-CH3C6H4), 5.42–5.48 [m, 1 H, o-CH3C6H4Ј {31P@δ = 1.0} 0.116 mmol) in CH2Cl2 (5 mL, 0 °C) a solution of BH3·THF in
δ = 5.45, d, JHH = 6.3], 5.30–5.35 [m, 1 H, o-CH3C6H4 {31P@δ =
THF (0.12 mL of ca. 1 m, 0.12 mmol) was added dropwise. The
solution was then warmed to room temperature and stirred for
30 minutes. The product was isolated as an orange powder, follow-
ing concentration of the solution in vacuo and the addition of ex-
3
3
3
24.1} δ = 5.33, d, JHH = 6.4], 4.99 (d, JHH = 6.1, 1 H, m-
3
CH3C6H4Ј), 2.79 [sept, JHH = 6.9, 1 H, CH(CH3)2], 1.28 (s, 3 H,
3
3
CH3–C6H4), 1.23 [d, JHH = 6.4, 3 H, CH(CH3)2], 1.21 [d, JHH
=
6.4, 3 H, CH(CH3Ј)2]. 13C{1H} NMR (CDCl3): δ = 134.0 [d, JPC cess hexane. Yield: 0.06 g (78%). Orange crystals suitable for X-
2
2
= 9.6, RuP(o-C6H5)3], 133.6 [d, JPC = 21.8, pend-P(o-C6H5)2 or
ray diffraction were obtained by slow diffusion of pentane into a
chloroform solution of 1B at room temperature. 1H NMR (CDCl3):
δ = 7.9–8.1 [m, 4 H, RuP(o-C6H5)2; {31P@δ = 22.7} δ = 8.02, d,
2
pend-P(o-C6ЈH5)2], 133.0 [d, JPC = 21.0, pend-P(o-C6ЈH5)2 or
pend-P(o-C6H5)2], 132.5 [d, 1JPC = 47.9, P(i-C6H5)2], 132.4 [d, 2JPC
4
= 9.9, RuP(o-C6ЈH5)2], 131.7 [d, JPC = 2.3, P(p-C6H5)2], 131.3 [d,
3JHH = 7.1], 7.35–7.44 [m, 4 H, P(o-C6H5)2BH3; {31P@δ = 11.9} δ
2JPC = 10.8, RuP(o-C6H5)2], 130.9 [d, 4JPC = 2.3, P(p-C6H5)3], 130.5 = 7.39, d, JHH = 7.2], 7.1–7.35 [m, 12 H, P(m,p-C6H5)2], 5.23 (d,
3
[d, 1JPC = 47.4, P(i-C6H5)3], 130.2 [d, 4JPC = 2.9, P(p-C6H5)2], 129.7
3JHH = 5.6, 2 H, o-CH3C6H4), 5.11 (d, JHH = 6.0, 2 H, m-
3
3
2
3
[s, CCH(CH3)2], 129.4 [d, JPC = 11.3, pend-P(m-C6H5)2 or pend-
CH3C6H4), 3.92 (t, JPH = 10.4, 2 H, P–CH2–P), 2.49 [sept, JHH
3
3
P(m-C6ЈH5)2], 128.4 [d, JPC = 10.5, pend-P(m-C6ЈH5)2 or pend-
= 6.9, 1 H, CH(CH3)2], 1.79 (s, 3 H, CH3–C6H4), 0.87 [d, JHH =
P(m-C6H5)2], 129.1 [d, JPC = 11.2, RuP(m-C6H5)2], 128.4 [d, JPC 6.9, 6 H, CH(CH3)2], 0.1–1.2 [br., 3 H, BH3; {11B@δ = –38.4} δ =
3
3
3
2
2
= 10.5, RuP(m-C6H5)3], 128.3 [d, JPC = 11.9, RuP(m-C6ЈH5)2],
0.70, d, JPH = 15.6]. 13C{1H} NMR (CDCl3): δ = 133.9 [d, JPC
2
114.8 (m, RuPPh2CCPPh2), 100.3 (s, CH3–C), 99.0 (s, o-CH3C6H4
= 9.7, RuP(o-C6H5)2], 131.4 [d, JPC = 9.6, P(o-C6H5)2BH3], 131.2
2
2
4
4
and o-CH3CЈ6H4), 91.0 (d, JPC = 9.6, m-CH3C6H4), 90.4 (d, JPC [d, JPC = 2.5, RuP(p-C6H5)2], 130.5 [d, JPC = 2.3, P(p-C6H5)2-
3
= 9.4, m-CH3C6ЈH4), 31.3 [s, CH(CH3)2], 21.6 [s, CH(CH3)2 or BH3], 129.5–130.5 [m, P(i-C6H5)2], 128.5 [d, JPC = 10.2, P(m-
CH(CЈH3)2], 21.1 [s, CH(CЈH3)2 or CH(CH3)2], 15.5 (s, CH3– C6H5)2], 127.9 [d, 3JPC = 10.3, P(m-C6H5)2], 108.7 [s, CCH(CH3)2],
2
2
2
C6H4). 31P{1H} NMR (CDCl3): δ = 24.2 (d, JPP = 55.1, 1 P, Ru–
94.3 (s, CH3–C), 90.2 (d, JPC = 4.3, o-CH3C6H4), 85.5 (d, JPC =
3
2
PPh3), 1.0 (dd, JPP = 3.2, JPP = 55.1, 1 P, Ru–PPh2), –31.7 (d,
6.0, m-CH3C6H4), 30.0 [s, CH(CH3)2], 21.4 [s, CH(CH3)2], 17.2 (s,
3JPP = 4.9, 1 P, pend-PPh2), –144.4 (sept, JPF = 712.7, 1 P, PF6).
CH3–C6H4), 16.7 (dd, 1JPC = 19.4, 1JPC = 24.3, P–CH2–P). 31P{1H}
1
IR (nujol, cm–1): ν
= 2105 (w). ESI-MS (MeOH) positive ion:
NMR (CDCl3): δ = 22.7 (d, JPP = 29.2, 1 P, Ru–P), 11.9 (br., 1 P,
2
˜
ν(CC)
m/z = 533 (15) [M – PPh2CCPPh2]+, 665 (20) [M – PPh3]+, 927 P–BH3). 11B{1H} NMR (CDCl3): δ = –38.4 (br). IR (nujol, cm–1):
(100) [M]+. ESI-MS2 (+927): m/z = 665 [M – PPh3]+. ESI-MS nega-
tive ion: m/z = 145 [PF6]–. C54H49ClF6P4Ru·0.75CH2Cl2 (1136.09):
calcd. C 57.88, H 4.48; found C 57.54, H 4.53.
ν
= 2419 (br), 2389 (br). C35H39BCl2P2Ru·CH2Cl2 (789.36):
˜
ν(BH)
calcd. C 54.78, H 5.24; found C 55.24, H 5.26.
Preparation of [(η6-p-Cymene)RuCl2(η1-PPh2CH2CH2PPh2BH3)]
(8B): To a solution of dppe (0.104 g, 0.26 mmol) in CH2Cl2 (10 mL,
0 °C) a solution of [(η6-p-cymene)RuCl2]2 (0.100 g, 0.16 mmol) in
CH2Cl2 (5 mL) followed, ca. 1 min later, by a solution of BH3·THF
in THF (0.16 mL of ca. 1.2 m, 0.19 mmol)] were added rapidly. The
solution was then warmed to room temperature and stirred for 1 h.
The solvent was then removed in vacuo, and the residue extracted
with toluene (25 mL). Further [(η6-p-cymene)RuCl2(μ-dppe)-
Preparation
of
[(η6-p-Cymene)RuCl(PPh3)(η1-PPh2CCPPh2-
BH3)]PF6 (7B): To a solution of 7 (0.150 g, 0.12 mmol) in THF
(25 mL, –78 °C) a solution of BH3·THF in THF (0.10 mL of ca.
1.2 m, 0.12 mmol) was added dropwise. The solution was then
stirred for 1 h. The solvent was removed in vacuo as the solution
warmed to room temperature, the residue washed with diethyl ether
(2×20 mL) and then dried in vacuo. Yield: 0.095 g (78%). 1H
NMR (CDCl3): δ = 8.03 [dd, 3JHH = 7.6, 3JPH = 12.4, 2 H, RuP(o- RuCl2(η6-p-cymene)] could be separated from the reaction mixture
3
C6H5)2CCPPh2], 7.94 [dd, 3JHH = 7.4, JPH = 12.3, 2 H, pend-P(o-
by recrystallisation from CH2Cl2/pentane, at –20 °C. Purification
3
3
C6H5)2], 7.88 [dd, JHH = 7.4, JPH = 12.1, 2 H, pend-P(o-C6H5Ј)2], of the remaining material by preparative TLC (acetone/CH2Cl2,
4
3
7.1–7.7 (m, 27 H, PPh), 7.00 [td, JPH = 2.6, JHH = 7.6, 2 H,
1:11), extracting the first orange band with acetone, give the pure
Eur. J. Inorg. Chem. 2005, 4762–4774
© 2005 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjic.org
4771